Sfoglia per RIVISTA
BLOOD ADVANCES
Collezione AO Cuneo

  

Items : 9

Nonrestrictive diet does not increase infections during post-HSCT neutropenia: data from a multicenter randomized trial. in Blood advances / Blood Adv. 2023 Oct 10;7(19):5996-6004. doi: 10.1182/bloodadvances.2023010348.

2023
AO Cuneo

Stella F; Marasco V; Levati GV; Guidetti A; De Filippo A; Pennisi M; Vismara C; Miceli R; Ljevar S; Tecchio C; Mordini N; Gobbi G; Saracino L; Corradini P;

Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial. in Blood advances / Blood Adv. 2023 Jul 25;7(14):3764-3774. doi: 10.1182/bloodadvances.2022009504.

2023
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
AOU Alessandria

Ladetto M; Di Paolo A; Cortelazzo S; Galimberti S; Palumbo GA; Puccini B; Ferreri AJM; Ballerini F; Lucchini E; Arcaini L; Moita F; Zilioli V; Balzarotti M; Cavallo F; Boccomini C; Stefoni V; Re A; Di Rocco A; Genuardi E; De Luca G; Ghislieri M; Tavarozzi R; Alessandria B; Pironti M; Zaccaria GM; Arrigoni E; Grimaldi D; Ferrero S;

Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial. in Blood advances / Blood Adv. 2023 Aug 22;7(16):4448-4461. doi: 10.1182/bloodadvances.2022009596.

2023
AO Cuneo
AOU Città della Salute di Torino

Vitale A; Trappolini S; Guarini A; Latte G; Di Bartolomeo P; Cassibba V; Candoni A; Bonifacio M; De Fabritiis P; Bocchia M; Fracchiolla N; Mattei D; Martinelli G; Mauro E; Zappasodi P; Borlenghi E; Marbello L; Audisio E; Scattolin AM; De Propris MS; Elia L; Messina M; Paoloni F; Spinelli O; Santoro A; Della Starza I; Bassan R; Chiaretti S; Fazi P; et alii...

INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia. in Blood advances / Blood Adv. 2022 Mar 22;6(6):1742-1753. doi: 10.1182/bloodadvances.2021004821.

2022
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 1
AOU Novara

Baccarani M; Foà R; Fazi P; Vignetti M; Cavo M; Sartor C; Paolini S; Granier M; Wang M; Zhu Z; Abbenante MC; Galieni P; Fabbiano F; Trappolini S; Tosi P; Bonifacio M; Martelli MP; D'Ardia S; Cuneo A; Tedeschi A; Frison L; Bocchia M; Vitale A; Candoni A; Selleri C; Simonetti F; Lunghi M; de Fabritiis P; Lemoli RM; et alii...

Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study. in Blood advances / Blood Adv. 2022 Jun 28;6(12):3569-3578. doi: 10.1182/bloodadvances.2022007397.

2022
AO Cuneo
ASL Cuneo 1
ASL Cuneo 2
AOU Alessandria

Nardo B; Bertoletti L; Riva N; Schenone A; Di Nisio M; Lazo-Langner A; Martinelli I; Becattini C; De Stefano V; Pomero F; Tosetto A; Donadini MP; Ageno W; Beyer Westendorf J; Contino L; Bucherini E; Sartori MT; Senzolo M; Grandone E; Santoro R; Carrier M; Delluc A;

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.

2022
ASL Torino 5
ASL Biella
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 1
AOU Novara
AOU Alessandria

Ladetto M; Pilerci S; Pinto A; Ramadan S; Marchesi F; Cavo M; Musto P; Coviello E; Romano A; Passamonti F; Corradini P; Krampera M; Tosi P; Lanza F; Candoni A; Selleri C; Conconi A; Visani G; Vallisa D; Venditti A; Gambacorti-Passerini C; Rigacci L; La Barbera EO; Corso A; Armiento D; Cilloni D; Cardinali V; Galimberti S; Bocchia M; et alii...

Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes. in Blood advances / Blood Adv. 2022 Feb 22;6(4):1350-1360. doi: 10.1182/bloodadvances.2021005715.

2022
AO Cuneo

Cohen JB; Slager SL; Allmer C; Ansell SM; Witzig TE; Paludo J; Inwards DJ; Habermann TM; Syrbu SI; Feldman AL; Farooq U; Link BK; Maurer MJ; Larson MC; Wang Y; Castellino A; Martin P; Cerhan JR; Nowakowski GS;

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP. in Blood advances / Blood Adv. 2019 Dec 23;3(24):4280-4290. doi: 10.1182/bloodadvances.2019000865.

2019
AOU Città della Salute di Torino
AO Cuneo
AOU Alessandria
AOU Novara

Soverini S; Vigneri P; Rosti G; Bonifacio M; Breccia M; Castagnetti F; Saglio G; Pane F; Russo D; Trabacchi E; Spadano R; Stagno F; Tiribelli M; Tomassetti S; Sancetta R; Sica S; Salvucci M; Rupoli S; Rege-Cambrin G; Rapezzi D; Pregno P; Miggiano MC; Montefusco E; Musolino C; Palmieri F; Malagola M; Melpignano A; Martino B; Marasca R; et alii...

Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML. in Blood advances / Blood Adv. 2019 Apr 9;3(7):1103-1117. doi: 10.1182/bloodadvances.2018026625.

2019
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Falini B; Bosi A; Cortelazzo S; Audisio E; Oldani E; Spinelli O; Zanghì P; Ferrero D; Cortelezzi A; Corradini P; Campiotti L; Scattolin AM; Todisco E; Bernardi M; Borlenghi E; Ciceri F; Cattaneo C; De Paoli L; Cavattoni I; Mattei D; Terruzzi E; Marmont F; Gianfaldoni G; Boschini C; Pavoni C; Masciulli A; Bassan R; Intermesoli T; Pogliani EM; et alii...